Stephen L. Huhn
CIK 1863904 · CMO & Sr VP, Clinical Dev. · last filed 2025-01-31
Stephen L. Huhn is a CMO & Sr VP, Clinical Dev. who has filed 3 SEC Form 4 insider transactions across 1 company since 2024. The most recent filing, for CTNM, was dated Jan 31, 2025. Current disclosed insider exposure totals $152.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$152.1K
1
3
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CTNM | CMO & Sr VP, Clinical Dev. | 12,800 | $11.88 | $152.1K | $0 | 3 | 2025-01-31 |
Recent Filings
3 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-01-31 | CTNM | Grant (A) | — | $0 | EDGAR |
| 2024-08-14 | CTNM | Exer (M) | +12,800 | $12.9K | EDGAR |
| 2024-05-29 | CTNM | Grant (A) | — | $0 | EDGAR |